Tuesday presentations – Hepatitis Summit

A0 – Frank Tacke, Welcome address + EASL recommendations on the treatment of HCV

A1 – Graham Foster, Hep C policy and care needs involving of all – turn the page

A2 – Philippa Easterbrook, from data collection to recommendation

A3 – Mojca Matitic, from recommendation to practice

A4 – Magdelena Harris, from peer to research

A5 – Anton Basenko, from patient to advocate

Roundtable 1 – John Dillon

Roundtable 1 – Hans Haltmayer

Roundtable 2 – Maka Gogia

Wednesday presentations – Hepatitis Summit

A6 – Mesfin Ali, engaging migrants, barriers to testing and treatment

A7 – Esther Croes, thirty years of harm reduction in the Netherlands

A8 – Heino Stöver, hepatitis in prison settings

A9 – Natalia Kravchenko, access in EECA countries

A10 – Elisabetta Teti, meet, test and treat

A11- Teresa Sousa, the experiences of GIRUGaia

A12 – Raphael Schubert, directly observed therapy of chronic Hepatitis-C with interferon-free regimens at a low-threshold drug treatment

A13- Stephan Bourgeois, Free Clinic’s HCV treatment and peer model

A14 – Céline Grillon, MapCrowd, a community-based tool for advocating toward universal access to hepatitis c prevention and care

A15 – Deeba Shahidi, a creative action guide around a “Pill Proposal” developed by Universities Allied for Essential Medicines

A16 – Antoniu Llort Suárez, advocacy video’s from drug users in community health action

A17 – Zuure (udo), MSM

A18 – Julia del Amo, on the move workshop

A19 – Julie Bouscaillou, Facilitating access to hepatitis c treatment to people who inject drugs in Georgia – results of a peer support intervention

A20 – Amie Joof, HIV/HCV treatment advocacy for Africans in the United Kingdom

A21 – John Loftus and Billie, peer and interagency support initiatives

A22 – Magda Ferreira, tailored, peer driven interventions related to hepatitis c

A23 – Peter Wiessner, HIV-HCV community-based counseling and testing in prison

A24 – Elisa Martró, one-step screening of active hepatitis c virus infection in HIV-negative men who have sex with men, male sex workers and trans women sex workers

A25 – Martyna Gassowski, unsafe use, knowledge and HCV infection

A26 – Anne Oevrehus, Monitoring HCV infecions and HCV testing behaviors among people who enter into treatment for drug use in Southern Denmark

A27 – Oli Wehrli, the fight of the Swiss liver patient organisation to make DAA’s available for every patient

A28 – Giten Khwairakpam, Generic DAAs, pricing and availability

A29 – James Freeman, Buyer’s Clubs

A30 – Esteban Burrone, Increasing access to DAAs on low- and middle income countries

A31 – Sergey Golovin, Compulsory license and patent opposition activities in Russia

A32 – Sergiy Kondratyuk, pre-grant patent opposition as an instrument to avoid patent monopolies for medicines

A33 – Jeff Lazarus, the 2016 Hep-CORE Report